Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$4.78 - $15.01 $16,170 - $50,778
3,383 Added 23.26%
17,929 $94,000
Q3 2022

Nov 07, 2022

SELL
$10.22 - $23.7 $23,894 - $55,410
-2,338 Reduced 13.85%
14,546 $168,000
Q2 2022

Aug 12, 2022

BUY
$4.35 - $15.85 $73,445 - $267,611
16,884 New
16,884 $191,000
Q1 2022

May 10, 2022

SELL
$4.55 - $6.41 $116,439 - $164,038
-25,591 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$5.89 - $9.73 $150,730 - $249,000
25,591 New
25,591 $151,000
Q3 2021

Nov 15, 2021

SELL
$6.78 - $9.89 $70,152 - $102,331
-10,347 Closed
0 $0
Q2 2021

Aug 05, 2021

SELL
$7.24 - $11.2 $2,743 - $4,244
-379 Reduced 3.53%
10,347 $84,000
Q1 2021

May 17, 2021

BUY
$8.05 - $20.78 $86,344 - $222,886
10,726 New
10,726 $116,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $52.1M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.